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The mechanism of allergic diseases is still scarcely clarified, but there is 
sufficient reason to assume that it is based on antigen-antibody reaction. Not 
a single symptom or syndrome exists that is endowed with the value of a de-
finitive proof for the allergic genesis of a given disease (V. Hadorn — 1969). 
In discussing various allergic reactions, it becomes evident that they differ 
from each other essentially by clinical course and manifestation (M. Werner 
et al — 1968). Since antigen-antibody interaction underlies the mechanism in 
all similar reactions (A. D. Ado — 1970), the phenomenon could be reasonably 
considered as an immunologic one. Nowadays, it is accepted that the aller-
gic state is one of the phases of a complex biological process, occurring and 
forming in the course of immunity development (V. D. Timakov— 1973). 
In all diseases with an allergic genesis, the generalization of clinical data 
past history, clinical course, paraclinical and allergic (in vitro) studies is es-
sential for the diagnosis (A. Astrug — 1974). The immunologic tests for eluci-
dating some of the allergic reactions, in vitro, are classified in two large groups: 
serologic and cytologic (V. Valchanov, R. Popivanov— 1972). Such re-
actions demonstrate the formation of antigen-antibody complex, or the pre-
sence of antibodies in the patient's serum and cells (F . Austen, E . Becker — 
1971). Reference was already made to the mutual relationship between immu-
nity and allergy. However, the problem of natural immunity in the listed condi-
tions is quite different. It is well known that its factors undergo modifications 
in practically any morbid condition, and more particularly, one of its basic 
factors — the lysozyme ( E . Maron, B . Bonavida — 1971; K . Metodiev — 1976 a 
and 1976 b and many others). The protective action of lysozyme is very clearly 
manifested in the immunity of conjunctiva and cornea, oral cavity, pharynx, 
nose, sinuses and upper airways. In this context, the purpose of this work is 
to establish the changes in blood serum lysozyme values of patients with af-
fections mainly localized in the listed above parts of the human organism (al-
lergic rhinitis, sinusitis, bronchitis and bronchial asthma). 
Material and methods 
The study covers a total of 76 patients with allergic rhinitis (19—25.0 
per cent), allergic sinusitis (12—15.8 per cent), allergic bronchitis (27—35.5 per 
cent) and bronchial asthma (18—23.7 per cent). Blood was taken from each 
patient, in the aliergologic office of the faculty polyclinic — Varna, while 
lysozyme quantity was determined in the Chair of Microbiology and Virology of 
the Medical Faculty — Varna. The quantitative method of F . Elliott (1966), 
as modified by Zucker (1970) was used. The results of lysozyme value deter-
£ inations in biological fluids of healthy individuals served as controls ( K . Me-
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todiev — 1976 c). No statistical difference in the results of the investigated 
men and women was established. The same holds true for the age of the sub­
jects under study: mean age 21.4 years (the youngest 17.2, and the oldest — 
38.6 years). 
















Results and discussion 
The results of quantitative lysozyme determinations in the serum of pa­
tients are expressed in mcg/ml or gamma. The mean lysozyme amount in 
the serum of the subjects from the various groups is the following: allergic 
sinusitis patients — 9.7 mcg/ml; allergic rhinitis patients —10.9 mcg/ml; 
allergic bronchitis patients — 13.1 
T a b l e 1 mcg/ml, and bronchial asthma patients. 
(in paroxysm) — 14.8 mcg/ml. These 
values are a substantially higher than 
lysozyme values in the serum of healthy 
persons — averaging 6.2 mcg/ml in 
a total of 185 investigated individuals. 
Expressed in percentages, the rise of 
values ranges from 100 per cent among 
healthy cases to 156.6 per cent among 
those with allergic sinusitis, to 176 per 
cent in patients with allergic rhinitis, 
211.3 per cent inpatients with allergic bronchitis, and up to 240 per cent among 
bronchial asthma patients. It becomes evident from the results submitted 
that against the background of an overall increase in the serum lysozyme 
amount of patients, in those with allergic sinusitis it is lower, showing a gra­
dual rise in allergic rhinitis and bronchitis and reaching maximum values, 
among patients with bronchial asthma, examined during paroxysm. The chan­
ges in lysozyme values outlined comply with those in paraclinical indicators 
and allergic tests in this particular group of affections. It was al­
ready pointed out above that in diseases with allergic genesis, the generali­
zation and analysis of clinical data, past history, clinical course, paralinical 
and allergic tests have an essential practical bearing on diagnosing. In the des­
cribed investigation of patients with changes involving mainly the area of 
the oral, nasal and sinus cavities, as well as the upper airways, the ascending 
gradation of serum lysozyme values in the separate groups is impressive. This 
is explained precisely by the analysis and generalization of the mentioned 
above parameters. It is well known that allergic sinusitis runs a mild course 
as compared to allergic rhinitis, irrespective of the fact that the anatomical 
closeness and mutual relations between sinus and nasal cavity very often re­
sult in a secondary focus within the sinuses, respectively the nose. The changes 
in allergic bronchitis and bronchial asthma are discussed under analogical 
aspects. As yet, allergic bronchitis is not recognized as an independent disease 
entity by all clinicists since it occupies an interim position between broncho-
spasm and chronic bronchitis and emphysema, on the one hand, and bron­
chial asthma, on the other. However, there is no doubt that spastic bronchi­
tis (the so-called allergic bronchitis) represents an early stage of bronchial 
asthma development, with certain exceptions, especially in childhood. Both 
in chronic allergic bronchitis, and in bronchial asthma, where it is much more 
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pronounced, as the result of allergic reaction chemical mediators are released 
(histamine, SRS-A, bradykinin, E L H F - A ) , outlining the symptomatics and 
course of the disease, along with various pathological variations on behalf 
of other organs and systems. Evidently, the listed above conditions demand 
an increase in the serum lysozyme quantity of patients, an increase which is 
in compliance with the changes in a number of other indicators, characteristic 
of the same diseases. Therefore, we feel that serum lysozyme assay in patients 
with a variety of allergic diseases would definitely contribute to the prompt 
and more precise diagnosis of conditions produced by allergic reaction. 
Conclusions 
1. Lysozyme quantity in the serum of patients with allergic diseases is 
igreater than in the serum of healthy individuals. 
2. Patients with bronchial asthma display the highest increase in serum 
lysozyme values, next ranking patients with allergic bronchitis, rhinitis and 
sinusitis. 
3. The gradation of changes in serum lysozyme quantity among patients 
from the various groups corresponds to the changes established by other 
investigations, as well as to the clinical course, severity and prognosis of the 
disease. 
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ЕСТЕСТВЕННЫЙ ИММУНИТЕТ И АЛЛЕРГИЯ. ИССЛЕДОВАНИЕ 
ЛИЗОЗИМА В СЫВОРОТКЕ КРОВИ БОЛЬНЫХ 
АЛЛЕРГИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ 
Кр. Методиев. Г. Капрелян, Л, Караиванова 
Р Е З Ю М Е 
Исследованы 76 больных различными аллергическими заболяваниями 
аллергическими ринитами — 19 (25%), аллергическими синуитами — 12 
(15,8%), аллергическими бронхитами — 27 (35,5%) и бронхиальной аст­
мой — 18 (23,7%). У каждого больного определялось количество лизозима 
в сыворотке крови. В виде контролей служили результаты количественного 
определения лизозима в биологических жидкостях 185 здоровых лиц. У всех 
исследованных количество лизозима было выше нормального. В сравнении 
со 100% у здоровых людей (6,2 мкг/мл), лизозим увеличивался до 156,5% 
у больных аллергическими синуитами (9,7 мкг/мл), до 176% у больных ал­
лергическими ринитами (10,9 мкг/мл), до 211,3% у больных аллергиче­
скими бронхитами (13,1 мкг/мл) и до 240% у больных бронхиальной аст­
мой (14,8 мкг/мл). 
Была обсуждана возможность предложить количественное определение 
лизозима в сыворотке крови больных алерргическими заболеваниями как 
параклинический метод исследования, вместе с остальными клиническими, 
параклиническими и аллергологическими параметрами. 
